Jobs - The University of York

Exciting #postdoc opportunity in #biocatalysis and #oligonucleotide synthesis in my group at the University of York. Check out the details at jobs.york.ac.uk/vacancy/post...

Last date to apply is 8th March. Reach out to me if interested.

Entering the era of precision medicine to treat amyotrophic lateral sclerosis - Molecular Neurodegeneration With the disease modifying therapy Qalsody (tofersen) which targets the RNA product of the SOD1 gene, having been shown effective in amyotrophic lateral sclerosis (ALS), the present perspective seeks ...

'Entering the era of precision medicine to treat #AmyotrophicLateralSclerosis'

Frances Theunissen, Loren Flynn, Alfredo Iacoangeli...Masha Strømme & P. Anthony Akkari @murdoch.edu.au @kingscollegelondon.bsky.social #ALS #oligonucleotide

molecularneurodegeneration.biomedcentral.com/articles/10....

Spotlight On: Molecule of the Month :true:

The SCIEX 7500+ system excels in #oligonucleotide analysis, providing enhanced robustness and sensitivity—erfect for pharmacokinetic studies with limited samples.

Learn more about oligos and cutting-edge SCIEX solutions in the Spotlight on series: bit.ly/41sahev

#SpotlightOn #LCMSanalysis #Oligos

Oligonucleotide Pool Market Size, Growth, Trends, Forecast to 2032 | MRFR The Oligonucleotide Pool Market Share to Reach USD 3.17 Billion by 2032 at a CAGR of 8.30% during 2024-2032. Emerging Global Opportunities in Oligonucleotide Pool Market Technology, Size, Share, Major...

🧬 Accelerating research! The #Oligonucleotide market is fueling breakthroughs in genomics & drug discovery. 🚀
#Biotech #Genomics #LifeSciences
www.marketresearchfuture.com/reports/olig...

Oligonucleotide Conferences 2026 | mRNA Therapeutics Conferences 2026| RNA Therapeutics Conference 2026| Oligonucleotide Events 2026 | Oligonucleotide Meetings 2026 | World Conference on Oligonucleoti... Oligonucleotide Conferences 2026 , mRNA Therapeutics Conferences 2026, RNA Therapeutics Conference 2025, Oligonucleotide Events 2026 , Oligonucleotide Meetings 2026, World Conference on Oligonucleotid...

@otdc-2026.bsky.social Oligonucleotide Therapeutics and Delivery Conference is all set to happen on March 23-24, 2026 as a hybrid event in Rome, Italy
oligo-nucleotide.com
#RareDisease #LCA10 #Blindness #oligonucleotide

Nice 80% #RNAediting efficiency in patient-derived cells at therapeutically relevant #oligonucleotide concentrations. If #ProQR can take advantage of #FDA platform pathway, #Rett opportunity very exciting.

#WaveLifeSciences, once saying they are out of correcting mutations, are also on it.

Oligonucleotide CDMO Market Anticipated to Surge to $6.73 Billion by 2029 at 21.8% CAGR The Oligonucleotide CDMO market is projected to reach $6.73 billion by 2029, driven by increased demand for personalized medicine and advanced manufacturing solutions.

Oligonucleotide CDMO Market Anticipated to Surge to $6.73 Billion by 2029 at 21.8% CAGR #United_States #Delray_Beach #MarketsandMarkets #CDMO #Oligonucleotide

Postdoctoral Fellow – Development of next generation Oligonucleotide Therapeutics with enhanced efficacy and tissue selectivity at AstraZeneca Learn more about applying for Postdoctoral Fellow – Development of next generation Oligonucleotide Therapeutics with enhanced efficacy and tissue selectivity at AstraZeneca

#PostDoc opportunity – #Oligonucleotide therapeutics with enhanced efficacy & tissue selectivity at AstraZeneca (Gothenburg Sweden) ref: R-215834 | duration: 3 years | closing: 31-Jan-2025 #SynChem#MedChem #ChemPostDoc #PostDocJobs #chemsky 🧪
careers.astrazeneca.com/job/gothenbu...